Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
Qual Life Res ; 27(12): 3217-3227, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30132254

ABSTRACT

PURPOSE: Assistive technologies are widely implemented in clinical and research settings. Despite their dissemination, the psychosocial impact of their adoption still deserves further consideration. The aim of the present study is to determine the degree of compatibility between the Psychosocial Impact of Assistive Devices Scale (PIADS) and the International Classification of Functioning, Disability, and Health (ICF). METHODS: Six health professionals (two neurologists, one neuro-rehabilitation technician, two psychologists, one university professor of rehabilitation) created a technical board to discuss upon the PIADS-ICF linking. The standardized linking methodology was applied, and a Delphi technique was used to examine consensus. RESULTS: Five Delphi sessions were required to reach 100% of consensus and to finalize the procedure. Of the 26 PIADS' items, 23 were linked to an ICF category: 9 items were endorsed at the 3rd ICF level, and 14 items at the 2nd ICF level. Two items were classified as "not defined" and 1 item as "not covered". CONCLUSION: The study highlighted the conceptual connection between the PIADS and the ICF framework and set a bio-psychosocial standpoint by which accounting the role of assistive devices in rehabilitation settings.


Subject(s)
Disability Evaluation , International Classification of Functioning, Disability and Health/standards , Quality of Life/psychology , Self-Help Devices/standards , Activities of Daily Living , Humans
2.
Eur J Phys Rehabil Med ; 50(5): 495-504, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24651209

ABSTRACT

BACKGROUND: Physical modalities such as vibration has been suggested as possible non-pharmacological way to control spasticity. AIMS: The hypotheses tested were: 1) can a selective vibration of the upper limb flexor antagonist, triceps brachii, reduce the spasticity of the flexor biceps brachii muscle; 2) is its association with physiotherapy better than physiotherapy alone in reducing spasticity and improving function, 3) can this possible effect last for longer than the stimulation period. DESIGN: Randomized double-blind study. SETTING: Rehabilitation Institute, inward patients. POPULATION: Thirty hemiplegic patients affected by upper limb spasticity. METHOD: (VIB + PT) group received physiotherapy plus vibration by means of a pneumatic vibrator applied over the belly of the triceps brachii of the spastic side (contact surface 2 cm2; frequency 100 Hz; amplitude 2 mm; mean pressure 250 mBar). (SHAM + PT) group received physiotherapy and sham vibration. Both groups had 60 minutes of physiotherapy (Kabat techniques) for 5 days a week (from Monday to Friday) for 2 weeks. MAIN OUTCOME MEASURE: Ashworth modified scale for spasticity and robot-aided motor tasks changes for functional modifications were evaluated before starting treatment (T0), 48 hours after the fifth session (T1) and 48 hours after the last session (T2). RESULTS: Fisher's exact test showed a statistically significant greater improvements in the (VIB + PT) group (P=0.0001) compared to in the (SHAM + PT) group after 1 week, as well as after 2 weeks of treatment (P=0.0078) at the Ashworth scale. CONCLUSION: 1) 100 Hz vibration applied to the triceps brachii of a spastic upper limb in association with physiotherapy is able to reduce the spasticity of the flexor agonist, biceps brachii; 2) this association is better than physiotherapy alone in controlling spasticity and improving function; 3) this clinically perceivable reduction of spasticity and function improvement extends (for at least 48 hours) beyond the period of application of the vibration, supporting its possible role in the rehabilitation of spastic hemiplegia. CLINICAL REHABILITATION IMPACT: 100 Hz antagonist muscle vibration, a non-pharmacological treatment, can help physiotherapy to reduce flexors spasticity and improve functions in the rehabilitation of upper limb spasticity.


Subject(s)
Hemiplegia/complications , Muscle Spasticity/therapy , Physical Therapy Modalities , Upper Extremity , Vibration/therapeutic use , Aged , Double-Blind Method , Female , Hemiplegia/physiopathology , Humans , Male , Middle Aged , Motor Activity , Muscle Spasticity/etiology , Muscle Spasticity/physiopathology , Muscle, Skeletal , Treatment Outcome
3.
Eur Rev Med Pharmacol Sci ; 17(10): 1314-20, 2013 May.
Article in English | MEDLINE | ID: mdl-23740443

ABSTRACT

OBJECTIVES: Aims of the study were to assess the effects of rifaximin treatment on small intestinal bacterial overgrowth (SIBO) prevalence and gastrointestinal symptoms. STUDY DESIGN: Fifty (50) irritable bowel syndrome (IBS) children were consecutively enrolled. All subjects underwent lactulose hydrogen/methane breath test (LBT) to assess SIBO before and one month after the treatment with rifaximin 600 mg daily for one week. All IBS patients filled out a Visual Analogic Scale (VAS) to assess and score gastrointestinal symptoms (abdominal pain, constipation, diarrhoea, bloating, flatulence) at baseline and one month after treatment. RESULTS: The prevalence of abnormal LBT in patients with IBS was 66% (33/50). LBT normalization rate was 64% (21/33). Compliance was excellent, and no relevant side-effects were observed during treatment. VAS score was significantly higher in IBS patients with abnormal LBT than SIBO negatives, and strongly improved after successful treatment. CONCLUSIONS: Rifaximin was effective and safe in SIBO treatment and IBS symptoms improvement in childhood. Double blind placebo-controlled interventional studies are warranted to verify the real impact of SIBO on gastrointestinal symptoms in children with IBS.


Subject(s)
Anti-Infective Agents/therapeutic use , Bacterial Infections/drug therapy , Intestine, Small/microbiology , Irritable Bowel Syndrome/microbiology , Rifamycins/therapeutic use , Adolescent , Bacterial Infections/diagnosis , Breath Tests , Child , Female , Humans , Lactulose , Male , Prospective Studies , Rifaximin
4.
Minerva Pediatr ; 65(1): 97-101, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23422579

ABSTRACT

Septo-optic dysplasia (SOD), otherwise called De Morsier syndrome, is a developmental anomaly of mid-line brain structures and includes optic nerve hypoplasia, absence of the septum pellucidum and hypothalamo-pituitary abnormalities). In literature an association between optic nerve hypoplasia and neonatal cholestasis is described. We report the case of a female infant with persistent cholestasis, low weight gain and onset of nystagmus that appeared at one month and a half of life. Ophthalmology evaluation showed left optic nerve hypoplasia. MRI scan of the brain demonstrated a thin left optic nerve, an ectoptic posterior pituitary gland, no visible infundibulum and lack of septum pellucidum. Endocrinological investigation showed GH and ACTH deficiency. We discuss about diagnosis and pathogenesis of De Morsier syndrome with a brief review of the literature.


Subject(s)
Cholestasis/diagnosis , Female , Humans , Infant, Newborn
5.
Childs Nerv Syst ; 28(7): 1063-8, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22349902

ABSTRACT

PURPOSE: Every year 300,000 children with accidental head trauma are admitted to Italian emergency departments. Our aims were: (1) to describe patients with minor traumatic brain injury who were admitted to pediatric departments and underwent CT, and (2) to analyze the appropriateness of management according to current guidelines. METHODS: We retrospectively analyzed patients with minor head injury (median age 4.5 years, range 1 month to 16 years) who were admitted to the pediatric department of the Catholic Medical School of Rome, from January 2005 to September 2010, who performed head CT. Univariate analysis was performed using the Fisher's exact test. Multivariate analysis was performed by logistic regression. RESULTS: One hundred and seventy-four patients were enrolled in the study. Fifty-four patients (31%) had pathological CT findings. Eight patients underwent neurosurgical treatments. Vomiting was the only symptom significantly prevalent in the infant group, compared to the children group (10.7% vs. 38.9%, p = 0.007), while loss of consciousness in the children group (50.0% vs. 25.0%, p = 0.040). The relationship between scalp swelling and CT abnormalities was statistically significant in the entire population. The incidence of head abnormalities was significantly higher in children with abnormal CT (92.6% vs. 72.5%). CONCLUSIONS: The best way to manage children with minor head trauma is still matter of debate. Loss of consciousness and scalp swelling are risk factors predicting brain injury that deserve CT control. The radiation risks posed by CT scanning in children must be balanced by the benefits. We believe that even though CT scans may be clinically unnecessary in many cases, the rate of scanning is justified by the even limited number of abnormalities which require neurosurgical treatment.


Subject(s)
Brain/diagnostic imaging , Craniocerebral Trauma/diagnosis , Tomography, X-Ray Computed , Adolescent , Brain/pathology , Child , Child, Preschool , Craniocerebral Trauma/epidemiology , Female , Glasgow Coma Scale , Humans , Infant , Infant, Newborn , Italy/epidemiology , Male , Multivariate Analysis , Retrospective Studies
6.
Eur Ann Allergy Clin Immunol ; 43(5): 157-61, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22145251

ABSTRACT

UNLABELLED: Preschool children frequently suffer from acute respiratory tract infections (ARTI). Immunostimulants (ISs) are often administered to reduce their impact. This study aimed to establish the efficacy of ISs in the prevention of pediatric ARTI through the analysis of systematic reviews (SRs). We explored Medline database in October 2010 limiting our search to SRs, that included studies on the effectiveness of ISs in the prevention of pediatric ARTI. Six SRs with meta analysis (MA) were found. The studies included showed a low methodological quality and a high statistical heterogeneity. All papers published on journals with impact factor > 1 and a Jadad score > 3 reviewed the efficacy of OM-85. The number needed to treat (NNT) was between 2 and 11, depending on the setting. CONCLUSIONS: Pediatric ARTI are a social and health care problem. When they impair the quality of life of the family a course of OM-85 might be warranted. Although scientific knowledge of clinicians may be improved by SRs, MA and aggregation of results may not always be the best way to accomplish this.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Nonprescription Drugs/administration & dosage , Research Design/statistics & numerical data , Respiratory Tract Infections/prevention & control , Acute Disease , Adjuvants, Immunologic/adverse effects , Child, Preschool , Education, Medical, Continuing/trends , Humans , Meta-Analysis as Topic , Nonprescription Drugs/adverse effects , Recurrence , Research Design/standards , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/physiopathology
7.
Eur Rev Med Pharmacol Sci ; 15(11): 1328-35, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22195368

ABSTRACT

BACKGROUND AND OBJECTIVES: Calprotectin is a protein especially expressed in neutrophil cytosol. In the last few years, Fecal calprotectin (FC) turned out to be a direct marker of gastrointestinal inflammation. Because of the simplicity of the method, it has been studied in several gastroenterologic diseases but no data are available about its concentration in children with small intestinal bacterial overgrowth (SIBO), a complex and not well known condition defined by an excessive germs proliferation, especially anaerobic, in the small bowel, and characterized by dyspeptic and malabsorption symptoms. The aim of this study was to evaluate FC values in children with SIBO, comparing to healthy subjects, in order to clarify if an inflammatory process coexists with SIBO. MATERIALS AND METHODS: We enrolled fifty-eight children affected by SIBO, as diagnosed by Lactulose Breath Test (LBT). They were assessed for FC values on stool samples. We compared them with a control population of 60 healthy children. RESULTS: In SIBO patients, a median value of 36.0 mg/kg and a mean value +/- SD of 43.0 +/- 31.6 mg/kg were calculated, while in healthy controls the median value was 29.5 mg/kg and the mean value +/- SD was 35.7 +/- 20.7 mg/kg, showing no statistically significant differences between the two groups (p = 0.07). CONCLUSIONS: FC values are negative in children affected by SIBO, not differing from those obtained in healthy children, suggesting that no subclinical intestinal inflammation involving neutrophils occurs in patients with higher proliferation of bacteria in the small bowel. The presence of high FC levels in children affected by SIBO might not be caused by bacterial overgrowth itself and, in this case, another cause should be investigated.


Subject(s)
Feces/chemistry , Infections/microbiology , Intestinal Diseases/microbiology , Intestine, Small/microbiology , Leukocyte L1 Antigen Complex/analysis , Breath Tests , Child , Female , Humans , Inflammation/pathology , Intestinal Diseases/pathology , Intestine, Small/pathology , Lactulose/analysis , Male , Prospective Studies
8.
Neurol Sci ; 32(1): 125-31, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21057842

ABSTRACT

To explore the experience of living with parkinsonism, a survey form was sent to the members of a patients' association; 1,256 forms were analysed. The mean age was 65.75 ± 9.29 years; 64.4% males. A family history was reported by 19.2%. Basic abilities were preserved in 75% of the responders; the ability to do indoor and outdoor activities was preserved in 42 and 28%, respectively. 70% of the responders liked to meet other people and about 50% liked discussing their condition. 80.3% of the responders lived with partner, while 7.8% did not live with family. Of the patients' partners, 38.9% took drugs, and 9.4% themselves needed assistance. Care programmes for parkinsonians should take into account the disease duration, the degree of disability, the presence of caregiver/s, and the level of caregiver burden; but it should also be appreciated that social habits, need of help, and severity of symptoms influence disability.


Subject(s)
Activities of Daily Living/psychology , Adaptation, Psychological , Parkinsonian Disorders/psychology , Quality of Life/psychology , Social Support , Aged , Analysis of Variance , Employment , Female , Health Surveys , Humans , Male , Marriage/statistics & numerical data , Middle Aged
9.
J Pediatr ; 155(3): 416-20, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19535093

ABSTRACT

OBJECTIVE: To assess the prevalence of small intestinal bacterial overgrowth (SIBO) in children affected by irritable bowel syndrome (IBS). STUDY DESIGN: Consecutive children affected by IBS according to Rome II criteria (n = 43) were enrolled at the Gemelli Hospital, Catholic University of Rome. The control population (n = 56) consisted of healthy subjects without IBS symptoms, similar to patients for age, sex, and social background. All subjects underwent lactulose/methane breath test (LBT) to assess small intestinal bacterial overgrowth. RESULTS: The prevalence of abnormal LBT result was significantly higher in patients with IBS (65%, 28/43) with respect to control subjects (7%, 4/56; OR 3.9, 95% CI 7.3-80.1, P < .00001). Patients with abnormal LBT showed a trend toward a worse visual analog scale score with respect to children with IBS without SIBO, but a significant statistical difference was observed only for bloating. CONCLUSIONS: Results from this study suggest a significant epidemiologic association between SIBO and IBS in childhood. Placebo-controlled interventional studies with antibiotics used to treat bacterial overgrowth are warranted to clarify the real impact of the disease on IBS symptoms.


Subject(s)
Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Intestine, Small/microbiology , Irritable Bowel Syndrome/epidemiology , Irritable Bowel Syndrome/microbiology , Adolescent , Bacterial Infections/diagnosis , Bacterial Infections/metabolism , Breath Tests/methods , Case-Control Studies , Child , Child, Preschool , Comorbidity , Female , Humans , Intestine, Small/metabolism , Irritable Bowel Syndrome/diagnosis , Lactulose/metabolism , Male , Methane/metabolism , Pain Measurement , Prevalence , Rome/epidemiology , Severity of Illness Index
10.
Aliment Pharmacol Ther ; 23(8): 1259-65, 2006 Apr 15.
Article in English | MEDLINE | ID: mdl-16611288

ABSTRACT

AIM: To compare the therapeutic effectiveness and tolerability of low daily doses of polyethylene glycol 4000 vs. lactulose in the treatment of neurogenic constipation in children with myelomeningocele. METHODS: Sixty-seven children with chronic neurogenic constipation were randomized allocated to receive either polyethylene glycol 4000 (0.50 g/kg) or lactulose (1.5 g/kg) for 6 months. Patients or their parents reported frequency and modality of evacuation and side effects on a diary card. Primary outcome was bowel frequency > or =3/week, and the second one was side effects at the end of treatment. RESULTS: Complete remission of constipation was reported by a significantly (P < 0.01) higher number of patients treated with polyethylene glycol compared with lactulose. At the end of the study, 46% patients of polyethylene glycol group and 22% of the lactulose group were asymptomatic. Compared with lactulose, patients treated with polyethylene glycol reported higher bowel frequency (5.1 vs. 2.9 bowel movements/week, P < 0.01) and reduction of encopresis. Neither lactulose nor polyethylene glycol caused clinically-significant serious side effects and palatability was similar. CONCLUSIONS: Polyethylene glycol 4000 compared with lactulose provided a higher success rate, without significant side effects, for the treatment of constipation in myelomeningocele children.


Subject(s)
Cathartics/therapeutic use , Constipation/complications , Lactulose/therapeutic use , Meningomyelocele/complications , Polyethylene Glycols/therapeutic use , Solvents/therapeutic use , Analysis of Variance , Child , Constipation/drug therapy , Female , Follow-Up Studies , Humans , Male , Meningomyelocele/drug therapy , Statistics, Nonparametric , Treatment Outcome
11.
Pediatr Med Chir ; 27(3-4): 99-102, 2005.
Article in Italian | MEDLINE | ID: mdl-16910459

ABSTRACT

The aim of this study is to verify the utility and safety of endoscopic procedures in the evaluation of children with clinically-significant gastrointestinal symptomatology. We report our experience of 87 pediatric endoscopy procedures including esophagogastroduodenoscopy, colonoscopy and tissue biopsies performed in 85 infants, children and adolescent, 3 months-15 years old, over a two-year period, june 2002-november 2004 after complete history, physical examination and basic investigations. General anesthesia was used in all patients after informed consent obtained from parents. Non significant complications were observed in this series of patients. In 81 cases (92.5%) with clinical symptoms and laboratory indications for gastrointestinal disease, the endoscopy and bioptical samples confirmed the utility and safety of procedure. Coeliac disease (39 cases), gastritis (11 cases), esophagitis (6 cases) were the most common organic cause of upper gastrointestinal disease. Allergic and indeterminate colitis (7 cases) were the most common cause of lower gastrointestinal disease. In 4.7% the procedures appear to be particularly helpful in the diagnosis of inflammatory lesions of the esophagus and stomach. In summary, the data demonstrate that endoscopy techniques show low morbidity, provide important diagnostic informations in pediatric gastrointestinal diseases and can be done safely in patients over 3 months of age.


Subject(s)
Endoscopy, Gastrointestinal , Gastrointestinal Diseases/diagnosis , Adolescent , Child , Child, Preschool , Endoscopy, Gastrointestinal/adverse effects , Endoscopy, Gastrointestinal/standards , Feasibility Studies , Humans , Infant , Retrospective Studies , Safety , Sensitivity and Specificity
12.
Childs Nerv Syst ; 20(6): 392-6, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15071749

ABSTRACT

INTRODUCTION: Several literature reports have demonstrated that cardiovascular disease is one of the most frequent pathologies in patients with spinal cord injury. AIM: The aim of this study is to reveal changes in the lipid profile in non-obese children with spina bifida/myelomeningocele (MMC). DISCUSSION: The original results demonstrate the necessity of metabolic surveillance in these patients. Daily physical activity must be ensured early on frequency in non-able-bodied children in order to prevent changes in seric lipoproteins.


Subject(s)
Lipids/blood , Spinal Dysraphism/blood , Spinal Dysraphism/physiopathology , Adolescent , Case-Control Studies , Child , Child, Preschool , Female , Humans , Hyperinsulinism/etiology , Infant , Male , Risk Factors , Sex Factors , Spinal Dysraphism/epidemiology , Walking/physiology
13.
G Ital Med Lav Ergon ; 25(2): 161-4, 2003.
Article in Italian | MEDLINE | ID: mdl-12872500

ABSTRACT

BACKGROUND AND PURPOSE: The constant increase in health costs in recent years has led to the introduction of instruments such as DRG--diagnosis-related groups--with the declared aim of best rationalizing in-hospital costs. As part of this rationalisation it has become necessary to identify the causes of prolonged admissions in health-care structures. As far as concerns the rehabilitation of cerebrovascular diseases, attention has been centred on the presence of post-stroke depression. Our study was aimed at analysing the effect of depression on the time spent in hospital and whether the depression also affected on the patient's potential for functional recovery. METHODS: Patients with acute cerebrovascular lesions admitted to our center for rehabilitation were enrolled in this study. Depressive syndromes and functional deficits were evaluated at admission and discharge. RESULTS AND CONCLUSIONS: The most depressed patients were those who spent a longer time in hospital, but they were also those who had a greater functional deficit. The depression did not affect the efficacy and efficiency of the rehabilitation treatment. The time spent in hospital did, however, correlate with the clinical condition of the patient at admission and the age of the lesion.


Subject(s)
Cerebrovascular Disorders/complications , Cerebrovascular Disorders/rehabilitation , Depression/epidemiology , Length of Stay/economics , Cerebrovascular Disorders/economics , Costs and Cost Analysis , Depression/etiology , Female , Humans , Incidence , Male , Middle Aged , Recovery of Function
15.
Funct Neurol ; 16(2): 135-41, 2001.
Article in English | MEDLINE | ID: mdl-11495419

ABSTRACT

Many instruments have been employed in recent years in order to quantify the posture and motion of the head in normal and pathological subjects. Evaluations of this type present many difficulties related to the influence of individual and external factors and to the accuracy of the system used. In patients with cervical dystonia (CD) the only rating scales currently used are semi-quantitative and subjective. More precise information on disease severity and response to the treatment is needed. Posture and motion of the head were evaluated by means of ELITE motion analyser (BTS, Milan, Italy) in 6 patients with the left laterocollis form of CD undergoing treatment with botulinum toxin (BTX). The method emerged as very useful for the quantification of the therapeutic response (which was more marked in motion than in posture). We found an inverse relationship between the degree of motion improvement and the restriction of motion before treatment.


Subject(s)
Anti-Dyskinesia Agents/therapeutic use , Botulinum Toxins/therapeutic use , Head , Torticollis/drug therapy , Torticollis/physiopathology , Adult , Biomechanical Phenomena , Female , Humans , Male , Middle Aged , Posture , Severity of Illness Index , Treatment Outcome
16.
Psychosom Med ; 62(3): 386-93, 2000.
Article in English | MEDLINE | ID: mdl-10845352

ABSTRACT

BACKGROUND: Modern management of Parkinson's disease (PD) aims to obtain symptom control, to reduce clinical disability, and to improve quality of life. Music acts as a specific stimulus to obtain motor and emotional responses by combining movement and stimulation of different sensory pathways. We explored the efficacy of active music therapy (MT) on motor and emotional functions in patients with PD. METHODS: This prospective, randomized, controlled, single-blinded study lasted 3 months. It consisted of weekly sessions of MT and physical therapy (PT). Thirty-two patients with PD, all stable responders to levodopa and in Hoehn and Yahr stage 2 or 3, were randomly assigned to two groups of 16 patients each. We assessed severity of PD with the Unified Parkinson's Disease Rating Scale, emotional functions with the Happiness Measure, and quality of life using the Parkinson's Disease Quality of Life Questionnaire. MT sessions consisted of choral singing, voice exercise, rhythmic and free body movements, and active music involving collective invention. PT sessions included a series of passive stretching exercises, specific motor tasks, and strategies to improve balance and gait. RESULTS: MT had a significant overall effect on bradykinesia as measured by the Unified Parkinson's Disease Rating Scale (p < .034). Post-MT session findings were consistent with motor improvement, especially in bradykinesia items (p < .0001). Over time, changes on the Happiness Measure confirmed a beneficial effect of MT on emotional functions (p < .0001). Improvements in activities of daily living and in quality of life were also documented in the MT group (p < .0001). PT improved rigidity (p < .0001). CONCLUSIONS: MT is effective on motor, affective, and behavioral functions. We propose active MT as a new method for inclusion in PD rehabilitation programs.


Subject(s)
Mood Disorders/therapy , Movement Disorders/therapy , Music Therapy/methods , Parkinson Disease/therapy , Female , Humans , Hypokinesia/therapy , Male , Middle Aged , Physical Therapy Modalities/methods , Prospective Studies , Quality of Life , Single-Blind Method , Surveys and Questionnaires , Treatment Outcome
18.
Blood Press Monit ; 5(5-6): 249-54, 2000.
Article in English | MEDLINE | ID: mdl-11153047

ABSTRACT

BACKGROUND: The introduction of ambulatory blood pressure monitoring into clinical practice has defined a clinical condition called 'isolated office hypertension'. OBJECTIVE: The aim of this study was to evaluate the long-term systolic and diastolic blood pressure changes in patients with isolated office hypertension and to identify the presence of markers capable of identifying which patients will develop sustained hypertension. METHODS: All the 407 patients enrolled had a random office systolic or/and diastolic blood pressure of over 140/90mmHg and a mean daytime ambulatory blood pressure of 130/84mmHg or less. At enrollment, each patient underwent a 'baseline examination' made up of a physical evaluation, a 24h ambulatory blood pressure monitoring, and a mental arithmetic test performed at the end of the 24h ambulatory monitoring. RESULTS: Of the 173 patients finally studied, 102 (58.9%) developed sustained hypertension with an increase in both ambulatory systolic and diastolic blood pressure. At the time of the baseline examination, the patients were divided into two groups. Group A included patients with mean ambulatory systolic and diastolic blood pressures in the first hour of 130/84mmHg or less; group B included patients with mean ambulatory systolic and diastolic pressures in the first hour of greater than 130/84mmHg. During the mental arithmetic test, the systolic and heart rate values increased significantly only in group B patients. Of the 102 patients who had become hypertensive by the time of the follow-up examination, 84 (82%) belonged to group B. CONCLUSION: These data suggest that isolated office hypertension may indeed be a transitional state towards the development of sustained hypertension. Moreover, the mean ambulatory blood pressure value during the first hour can be considered to be a marker of a higher risk of developing sustained hypertension.


Subject(s)
Blood Pressure/physiology , Hypertension/physiopathology , Workplace , Adult , Biomarkers , Blood Pressure Monitoring, Ambulatory , Female , Humans , Male
19.
J Pediatr Endocrinol Metab ; 11(6): 745-50, 1998.
Article in English | MEDLINE | ID: mdl-9829230

ABSTRACT

Autoimmune phenomena, especially occurrence of non organ-specific autoantibodies, are common in congenitally acquired HIV infection, mostly in the symptomatic stages of the disease. Anti-thyroid autoantibodies detected in adult patients represent the only type of organ-specific autoantibodies reported in HIV infection. As far as we know, occurrence of these autoantibodies has not been observed in HIV infected children. In this study thyroid biochemical pattern and possible occurrence of anti-thyroid autoantibodies were investigated in 40 vertically HIV infected, 18 seroreverted and 22 healthy children. 34% of HIV infected symptomatic children showed anti-thyroglobulin antibodies. Asymptomatic patients, seroreverted and healthy controls did not show any anti-thyroid antibodies at the time of the study. High Tg levels were observed in 38% of the 40 HIV infected patients and high TSH concentrations were found in 27.5% of the HIV children. High TSH values were more frequently observed in the infected children with moderate or severe immunocompromised status. Thyroxine binding globulin levels were high in 68% of the HIV children and in 22% of the seroreverted. The finding of anti-thyroid autoantibodies in congenital HIV infected children confirms the thyroid's involvement in HIV infection and provides more information about the wide spectrum of autoimmune phenomena observed in the infection.


Subject(s)
Autoantibodies/analysis , HIV Infections/immunology , HIV Infections/transmission , HIV-1 , Infectious Disease Transmission, Vertical , Thyroid Gland/immunology , CD4 Lymphocyte Count , Child, Preschool , Disease Progression , Female , HIV Infections/blood , HIV Infections/physiopathology , Humans , Male , Reference Values , Thyroglobulin/blood , Thyrotropin/blood , Thyroxine/blood , Thyroxine-Binding Proteins/analysis , Triiodothyronine/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...